Novel Direct-to-Brain Intracerebroventricular Stem Cell Phase 1 Trial Shows Safety and Exciting Results in Alzheimer’s
Regeneration Biomedical, Inc., a clinical-stage biotechnology company developing regenerative therapies for neurodegenerative diseases, today announced results from its first-in-human Phase 1 clinical trial of Wnt-activated autologous adipose-derived stem cells delivered…
